European Commission scientific committee steps up focus on devices
This article was originally published in SRA
Executive Summary
An opinion on the risk of products using nanotechnologies issued by the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks for the first time targets medical devices as a potential priority area for further assessment1. The commission plans to hold a hearing on the opinion later this year.